المؤلفون: Lekha Ramchandani, Jagannath Jatav, Di ya Bajaj, RK Vineeth Kumar

المصدر: National Journal of Laboratory Medicine, Vol 12, Iss 4, Pp PO29-PO34 (2023)

مصطلحات موضوعية: acute leukaemia, chronic leukaemia, lymphoid, myeloid, Microbiology, QR1-502, Chemistry, QD1-999

وصف الملف: electronic resource

Relation: https://www.njlm.net/articles/PDF/2774/62201_CE[Ra1]_F(SHU)_QC(AN_SHU)_PF1(HB_OM_SHU)_PFA(SHU)_PB(HB_SHU)_PN(SHU).pdf; https://doaj.org/toc/2277-8551; https://doaj.org/toc/2455-6882

URL الوصول: https://doaj.org/article/33aa8b60e20f4c83a5487d5fc89d7cb5

المؤلفون: Bibby, Lloyd

المساهمون: Ramsahoye, Bernard, Gilbert, Nicholas

مصطلحات موضوعية: acute leukaemia, molecular pathogenesis, high-throughput next generation DNA sequencing, leukaemia, tumour-only paired-end whole genome sequencing, chronic leukaemia, somatic structural rearrangements

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od_______463::e40763a05bd2a43735fae22ff979712a
https://hdl.handle.net/1842/37948

المؤلفون: Martine Escoffre-Barbe, P. Rousselot, Pascale Cony-Makhoul, Stéphane Bouchet, Lambert Busque, Caroline Dartigeas, Franck E. Nicolini, Valérie Coiteux, Françoise Huguet, Laurence Legros, Lydia Roy, Delphine Rea, François Guilhot, Joelle Guilhot, Emilie Cayssials, Francois-Xavier Mahon, Luigina Mollica, Agnès Guerci, Martine Gardembas, Jean-Michel Cayuela, Anne Bergeron, Gabriel Etienne, Viviane Dubruille, Aude Charbonnier, Mathieu Molimard

المساهمون: Centre Hospitalier de Versailles André Mignot (CHV), Infectious Diseases Models for Innovative Therapies (IDMIT), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay, Hôpital Maisonneuve-Rosemont, CIC - Poitiers, Université de Poitiers-Centre hospitalier universitaire de Poitiers (CHU Poitiers)-Direction Générale de l'Organisation des Soins (DGOS)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire de Nancy (CHU Nancy), Centre Léon Bérard [Lyon], Institut Bergonié [Bordeaux], UNICANCER, Hôpital Paul Brousse, Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Hôpital Claude Huriez [Lille], CHU Lille, CHU Trousseau [Tours], Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), CHU Pontchaillou [Rennes], Hôpital Henri Mondor, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Centre Hospitalier Annecy-Genevois [Saint-Julien-en-Genevois], Centre hospitalier universitaire de Nantes (CHU Nantes), Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM), Institut Universitaire du Cancer de Toulouse - Oncopole (IUCT Oncopole - UMR 1037), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Institut National de la Santé et de la Recherche Médicale (INSERM), Recherche clinique appliquée à l'hématologie (URP_3518), Université de Paris (UP), Hopital Saint-Louis [AP-HP] (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre hospitalier universitaire de Poitiers (CHU Poitiers), Bordeaux population health (BPH), Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Bordeaux Ségalen [Bordeaux 2], CHU de Bordeaux Pellegrin [Bordeaux], Bristol-Myers Squibb, CEA- Saclay (CEA), Commissariat à l'énergie atomique et aux énergies alternatives (CEA), Université de Versailles Saint-Quentin-en-Yvelines - UFR Sciences de la santé Simone Veil (UVSQ Santé), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Immunologie des maladies virales, auto-immunes, hématologiques et bactériennes (IMVA-HB), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Université de Toulouse (UT)-Université de Toulouse (UT)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Paris Cité (UPCité), CHU Toulouse [Toulouse]-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)

المصدر: British Journal of Haematology
British Journal of Haematology, Wiley, 2021, 194 (2), pp.393-402. ⟨10.1111/bjh.17654⟩
British Journal of Haematology, 2021, 194 (2), pp.393-402. ⟨10.1111/bjh.17654⟩

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Adolescent, medicine.drug_class, Pleural effusion, Dasatinib, Antineoplastic Agents, Gastroenterology, Tyrosine-kinase inhibitor, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Internal medicine, hemic and lymphatic diseases, Clinical endpoint, Humans, Medicine, Cumulative incidence, Prospective Studies, Adverse effect, Protein Kinase Inhibitors, Aged, 030304 developmental biology, Aged, 80 and over, Pharmacology, 0303 health sciences, Dose-Response Relationship, Drug, medicine.diagnostic_test, business.industry, Tyrosine kinases, Hematology, Middle Aged, medicine.disease, Effective dose (pharmacology), 3. Good health, Pleural Effusion, Treatment Outcome, Therapeutic drug monitoring, 030220 oncology & carcinogenesis, Chronic leukaemia, Female, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, Drug Monitoring, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccf07937e7bb76172bb58c0cabbf6bd0
https://hal.archives-ouvertes.fr/hal-03324903

المؤلفون: Lanza, F.^Aff2, Castoldi, G. L.

المساهمون: Fleischer, J., editor^Aff1

المصدر: Leukemias. :319-322

المؤلفون: Hussein, Kais, von Neuhoff, Nils, Büsche, Guntram, Buhr, Thomas, Kreipe, Hans, Bock, Oliver

المصدر: Annals of Hematology. November 2009 88(11):1059-1067

المؤلفون: Nikolas von Bubnoff, Cornelius Miething, Milena Pantic, Khalid Shoumariyeh, Saskia Hussung, Jürgen Finke, Christoph Niemöller, Torsten Haferlach, Pia Veratti, Sabine Bleul, Julian Riba, Juliane M Palmer, Dietmar Pfeifer, Björn Hackanson, Justus Duyster, Heiko Becker, Manja Meggendorfer, Ulrike Philipp, Marie Follo

المصدر: British Journal of Haematology. 190

مصطلحات موضوعية: Cbfb myh11, Transformation (genetics), Bcr abl1, Chronic leukaemia, business.industry, Mutant, Cancer research, Medicine, Hematology, Chronic myeloid leukaemia, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::847aa5ba8951d7ead793d149920bf805
https://doi.org/10.1111/bjh.16904

المؤلفون: Shamama Anwar, Afrin Alam

المصدر: Medicalbiological engineeringcomputing. 58(12)

مصطلحات موضوعية: Databases, Factual, Computer science, 0206 medical engineering, Feature extraction, Biomedical Engineering, 02 engineering and technology, Convolutional neural network, 030218 nuclear medicine & medical imaging, 03 medical and health sciences, 0302 clinical medicine, Chronic leukaemia, hemic and lymphatic diseases, medicine, Leukocytes, Humans, Segmentation, Training set, business.industry, Pattern recognition, Precursor Cell Lymphoblastic Leukemia-Lymphoma, 020601 biomedical engineering, Computer Science Applications, medicine.anatomical_structure, Blood smear, Lymphoblastic leukaemia, Bone marrow, Artificial intelligence, Neural Networks, Computer, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb97dbff2c91a838b77b702b3c1fc15d
https://pubmed.ncbi.nlm.nih.gov/33159270

المؤلفون: Kiesewetter, B., Cherny, N. I., Boissel, Nicolas, Cerisoli, F., Dafni, U., De Vries, Elisabeth G. E., Ghia, Paolo, Gökbuget, N., González-Calle, Verónica, Huntly, B., Jäger, U., Latino, N. J., Douillard, Jean-Yves, Malcovati, L., Mateos, M. V., Ossenkoppele, G. J., Porkka, K., Raderer, M., Ribera, Jose-Maria, Scarfò, L., Wester, R., Zygoura, P., Sonneveld, P., Universitat Autònoma de Barcelona

المساهمون: Hematology, Radiotherapy, CCA - Cancer Treatment and quality of life, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Kiesewetter, Barbara [0000-0002-5490-2371], Apollo - University of Cambridge Repository, Kiesewetter, B., Cherny, N. I., Boissel, N., Cerisoli, F., Dafni, U., De Vries, E. G. E., Ghia, P., Gokbuget, N., Gonzalez-Calle, V., Huntly, B., Jager, U., Latino, N. J., Douillard, J. -Y., Malcovati, L., Mateos, M. -V., Ossenkoppele, G. J., Porkka, K., Raderer, M., Ribera, J. -M., Scarfo', L., Wester, R., Zygoura, P., Sonneveld, P., HUS Comprehensive Cancer Center, Hematologian yksikkö, Helsinki University Hospital Area

المصدر: ESMO Open, 5. BMJ Publishing Group
Kiesewetter, B, Cherny, N I, Boissel, N, Cerisoli, F, Dafni, U, de Vries, E G E, Ghia, P, Gökbuget, N, González-Calle, V, Huntly, B, Jäger, U, Latino, N J, Douillard, J-Y, Malcovati, L, Mateos, M-V, Ossenkoppele, G J, Porkka, K, Raderer, M, Ribera, J-M, Scarfò, L, Wester, R, Zygoura, P & Sonneveld, P 2020, ' EHA evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for haematological malignancies ', ESMO OPEN, vol. 5, no. 1, e000611 . https://doi.org/10.1136/esmoopen-2019-000611
ESMO OPEN, 5(1):e000611. BMJ Publishing Group
ESMO Open, 5(1):000611. BMJ PUBLISHING GROUP
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
ESMO Open

مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, 3122 Cancers, value frameworks, ESMO-MCBS, Haematologic malignancies, Chronic lymphatic leukemia, Clinical benefit, 03 medical and health sciences, 0302 clinical medicine, QUALITY-OF-LIFE, Rating scale, Chronic leukaemia, REFRACTORY MULTIPLE-MYELOMA, Outcome Assessment, Health Care, medicine, Hematologic malignancy, Humans, ddc:610, Intensive care medicine, Grading (tumors), Societies, Medical, Original Research, 030304 developmental biology, RISK MYELODYSPLASTIC SYNDROMES, Solid tumour, 0303 health sciences, haematologic malignancies, business.industry, CHRONIC LYMPHOCYTIC-LEUKEMIA, Value frameworks, Myelodysplastic syndromes, clinical benefit, STEM-CELL TRANSPLANTATION, medicine.disease, LITY-OF-LIFE, 3. Good health, Clinical trial, LOW-DOSE CYTARABINE, Oncology, 030220 oncology & carcinogenesis, Hematologic Neoplasms, BORTEZOMIB-MELPHALAN-PREDNISONE, TRANSFUSION-DEPENDENT PATIENTS, OBINUTUZUMAB PLUS BENDAMUSTINE, business, NON-HODGKIN-LYMPHOMA

وصف الملف: application/pdf; text/xml

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afab66d40083bafe1f8491e208c2d914
https://pure.eur.nl/en/publications/bb5892b7-da0a-4ca4-abcf-2b2429eeebe8

المؤلفون: Lorenzo Rizzo, Maria Luisa Moleti, Anna Maria Testi, Nadia Vacca, Francesco Malaspina, Franco Locatelli, Roberta Burnelli, Maria Caterina Putti, Fiorina Giona, Andrea Biondi, Simona Bianchi, Rosamaria Mura, Saverio Ladogana, Giuseppe Saglio, Robin Foà

المساهمون: Giona, F, Malaspina, F, Putti, M, Ladogana, S, Mura, R, Burnelli, R, Vacca, N, Rizzo, L, Bianchi, S, Moleti, M, Testi, A, Biondi, A, Locatelli, F, Saglio, G, Foa, R

مصطلحات موضوعية: Male, Schedule, Pediatrics, medicine.medical_specialty, Adolescent, Paediatric haematology, chronic myeloid leukaemia, Antineoplastic Agents, Chronic myeloid leukaemia, Outcome (game theory), molecular studies, Chronic leukaemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, imatinib, paediatric haematology, therapy, molecular studie, Medicine, Humans, Child, business.industry, Imatinib, Hematology, Treatment Outcome, Settore MED/38 - PEDIATRIA GENERALE E SPECIALISTICA, Imatinib Mesylate, Female, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb633336462221b653ace4807546e475
http://hdl.handle.net/11573/1364771

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.